Tokyo Tape
Sign in
← Noile-Immune Biotech

Half-year report · Q2

4893.TEDINET S100UJB3
Period2024-01-01 → 2024-06-30
Filed2024-10-15
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed

Amends S100U7Q7.

Key figures · 42
MetricValuePeriodScopeSource row
Operating income−¥682m2024-01-01 → 2024-06-30StandaloneOperating income
Operating income−¥482m2023-01-01 → 2023-06-30StandaloneOperating income
Ordinary income−¥682m2024-01-01 → 2024-06-30StandaloneOrdinary income
Ordinary income−¥1.1bn2023-01-01 → 2023-12-31StandaloneOrdinary income loss (5-year summary)
Ordinary income−¥832m2023-01-01 → 2023-06-30StandaloneOrdinary income
Profit before tax−¥682m2024-01-01 → 2024-06-30StandaloneIncome before income taxes
Profit before tax−¥832m2023-01-01 → 2023-06-30StandaloneIncome before income taxes
Net income−¥683m2024-01-01 → 2024-06-30StandaloneProfit loss
Net income−¥1.1bn2023-01-01 → 2023-12-31StandaloneNet income loss (5-year summary)
Net income−¥834m2023-01-01 → 2023-06-30StandaloneProfit loss
Total assets¥5.1bnat 2024-06-30StandaloneAssets
Total assets¥5.8bnat 2023-12-31StandaloneAssets
Total assets¥6.1bnat 2023-06-30StandaloneTotal assets (5-year summary)
Total liabilities¥81mat 2024-06-30StandaloneLiabilities
Total liabilities¥91mat 2023-12-31StandaloneLiabilities
Net assets / equity¥5.0bnat 2024-06-30StandaloneNet assets
Net assets / equity¥5.7bnat 2023-12-31StandaloneNet assets
Net assets / equity¥5.9bnat 2023-06-30StandaloneNet assets (5-year summary)
Cash and deposits¥4.9bnat 2024-06-30StandaloneCash and deposits
Cash and deposits¥5.6bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥4.9bnat 2024-06-30StandaloneCash and cash equivalents
Cash & equivalents¥5.6bnat 2023-12-31StandaloneCash and cash equivalents
Cash & equivalents¥6.0bnat 2023-06-30StandaloneCash and cash equivalents
Cash & equivalents¥4.5bnat 2022-12-31dStandaloneCash and cash equivalents
Operating cash flow−¥611m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in operating activities
Operating cash flow−¥873m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥509m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in operating activities
Investing cash flow¥557,0002024-01-01 → 2024-06-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥5m2023-01-01 → 2023-12-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5m2023-01-01 → 2023-06-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥3m2024-01-01 → 2024-06-30StandaloneNet cash provided by used in financing activities
Financing cash flow¥1.9bn2023-01-01 → 2023-12-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥1.9bn2023-01-01 → 2023-06-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥-15.792024-01-01 → 2024-06-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-27.252023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥-21.032023-01-01 → 2023-06-30StandaloneBasic earnings loss per share (5-year summary)
Equity ratio98.3%at 2024-06-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio98.3%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio96.6%at 2023-06-30StandaloneEquity to asset ratio (5-year summary)
Shares issued43,301,765at 2024-06-30StandaloneTotal number of issued shares (5-year summary)
Shares issued43,276,765at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued43,202,865at 2023-06-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 354
ItemContextValueUnit
Operating costs1 cos exp oaCurrentYTDDuration_NonConsolidatedMember195000JPY
Research and development costs cos exp oaPrior1YTDDuration_NonConsolidatedMember286799000JPY
Research and development costs cos exp oaCurrentYTDDuration_NonConsolidatedMember423163000JPY
General and administrative expenses cos exp oaPrior1YTDDuration_NonConsolidatedMember204209000JPY
General and administrative expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember261045000JPY
Operating costs and expenses cos exp oaPrior1YTDDuration_NonConsolidatedMember492844000JPY
Operating costs and expenses cos exp oaCurrentYTDDuration_NonConsolidatedMember684403000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember-481500000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember-681816000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember22000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember28000JPY
Interest on refund noiPrior1YTDDuration_NonConsolidatedMember－JPY
Interest on refund noiCurrentYTDDuration_NonConsolidatedMember49000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember0JPY
Other noiCurrentYTDDuration_NonConsolidatedMember2000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember22000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember80000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember628000JPY
Foreign exchange losses noeCurrentYTDDuration_NonConsolidatedMember470000JPY
Listing expenses noePrior1YTDDuration_NonConsolidatedMember341602000JPY
Listing expenses noeCurrentYTDDuration_NonConsolidatedMember－JPY
Stock issuance cost noePrior1YTDDuration_NonConsolidatedMember8632000JPY
Stock issuance cost noeCurrentYTDDuration_NonConsolidatedMember－JPY
Non operating expensesPrior1YTDDuration_NonConsolidatedMember350863000JPY
Non operating expensesCurrentYTDDuration_NonConsolidatedMember470000JPY
Ordinary incomePrior1YTDDuration_NonConsolidatedMember-832341000JPY
Ordinary incomeCurrentYTDDuration_NonConsolidatedMember-682206000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-832341000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-682206000JPY
Income taxes currentPrior1YTDDuration_NonConsolidatedMember1213000JPY
Income taxes currentCurrentYTDDuration_NonConsolidatedMember1214000JPY
Income taxesPrior1YTDDuration_NonConsolidatedMember1213000JPY
Income taxesCurrentYTDDuration_NonConsolidatedMember1214000JPY
Profit lossPrior1YTDDuration_NonConsolidatedMember-833554000JPY
Profit lossCurrentYTDDuration_NonConsolidatedMember-683420000JPY
Income before income taxesPrior1YTDDuration_NonConsolidatedMember-832341000JPY
Income before income taxesCurrentYTDDuration_NonConsolidatedMember-682206000JPY
Interest income ope cfPrior1YTDDuration_NonConsolidatedMember-22000JPY
Interest income ope cfCurrentYTDDuration_NonConsolidatedMember-28000JPY
Listing expenses ope cfPrior1YTDDuration_NonConsolidatedMember341602000JPY
Listing expenses ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Stock issuance cost ope cfPrior1YTDDuration_NonConsolidatedMember8632000JPY
Stock issuance cost ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Foreign exchange losses gains ope cfPrior1YTDDuration_NonConsolidatedMember382000JPY
Foreign exchange losses gains ope cfCurrentYTDDuration_NonConsolidatedMember－JPY
Decrease increase in inventories ope cfPrior1YTDDuration_NonConsolidatedMember-4243000JPY
Decrease increase in inventories ope cfCurrentYTDDuration_NonConsolidatedMember9321000JPY
Decrease increase in advance payments ope cfPrior1YTDDuration_NonConsolidatedMember-133000JPY
Decrease increase in advance payments ope cfCurrentYTDDuration_NonConsolidatedMember-7100000JPY
Decrease increase in consumption taxes refund receivable ope cfPrior1YTDDuration_NonConsolidatedMember-59227000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-12-31pass
balance sheet identitynon_consolidated 2024-06-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-06-30pass
statement vs summary · operating cash flownon_consolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flownon_consolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-06-30pass